With their pending patent application, Bioxytran,
Post# of 101
(Total Views: 106)
Posted On: 10/26/2023 10:04:22 AM
With their pending patent application, Bioxytran, Inc. is primed to address a broad spectrum of viral diseases. Their commitment, mirrored in a substantial market cap and a trading range from $0.12 to $1.05, positions them as potential leaders in the biotech sector.
(0)
(0)Bioxytran, Inc. (BIXT) Stock Research Links
Scroll down for more posts ▼